gantacurium

Small moleculeexperimental

Gantacurium chloride is a new experimental neuromuscular blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in surgical anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Gantacurium is no longer in clinical development. — Wikipedia

Clinical trial activity

2 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2005 (NCT00235976)

Timeline

2000s

  1. Jan 1, 2005

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

COc1cc2c(cc1OC)[C@H](c1cc(OC)c(OC)c(OC)c1)[N@@+](C)(CCCOC(=O)/C=C(\Cl)C(=O)OCCC[N@+]1(C)CCc3cc(OC)c(OC)cc3[C@H]1Cc1cc(OC)c(OC)c(OC)c1)CC2
Mol. weight
993.59 g/mol
Lipinski Ro5
3 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • av430a
  • av430a
  • cw 002
  • cw 002
  • gantacurium
  • gantacurium
  • gantacurium
  • gantacurium chloride
  • gantacurium chloride
  • gantacurium chloride
  • gantacurium chloride
  • gw280430a
  • gw280430a
  • gw280430a
  • gw 280430a
  • gw-280430a

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01338935Phase 1May 1, 2011Cornell University
NCT00235976Phase 1/Phase 2 (Phase 2)May 1, 2005Avera Pharmaceuticals, Technical University of Munich
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Avera PharmaceuticalsFor profit1112005
Cornell UniversityAcademic/Hospital1112011
Technical University of MunichAcademic/Hospital1012005
3 organizations
Page 1 / 1